Lapatinib Terminated Phase 1 Trials for Estrogen Receptor Negative / HER2/Neu Positive / Stage IV Breast Cancer / Estrogen Receptor Positive / Recurrent Breast Carcinoma / Progesterone Receptor Negative / Progesterone Receptor Positive Treatment